Abcam ADS Holders who have any questions or require any assistance in submitting their voting instructions,
should contact the Companys proxy solicitor, Morrow Sodali, by calling (800) 662-5200 (toll-free in North America) or +1 (203) 658-9400 or by emailing
ABCM@info.morrowsodali.com.
Abcam shareholders are advised to ONLY use the BLUE Form of Proxy approved by the High Court of Justice of England and Wales
and issued by the Company for the Court Meeting and the YELLOW Form of Proxy issued by the Company for the General Meeting, or one of the other methods stated in the Shareholder Circular, to submit their proxy appointments in respect of the Court
Meeting and General Meeting so as to ensure that their votes are counted.
Abcam ADS Holders are advised to ONLY use the form of BLUE ADS Voting
Instruction Card prepared by the Depositary and approved by the Company in connection with the Court Meeting and General Meeting (whether by completing the form themselves or by following the instructions provided by their broker, bank or other
nominee or intermediary in connection therewith) so as to ensure that their voting instructions are counted.
PROXY APPOINTMENTS OR VOTING INSTRUCTIONS
SUBMITTED BY ANY OTHER MEANS MAY NOT BE ACCEPTED.
About Abcam plc
As an innovator in reagents and tools, Abcams purpose is to serve life science researchers globally to achieve their mission faster. Providing the
research and clinical communities with tools and scientific support, the Company offers highly validated antibodies, assays and other research tools to address important targets in critical biological pathways.
Already a pioneer in data sharing and ecommerce in the life sciences, Abcams ambition is to be the most influential company in life sciences by helping
advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health.
Abcams worldwide
customer base of approximately 750,000 life science researchers uses Abcams antibodies, reagents, biomarkers and assays. By actively listening to and collaborating with these researchers, the Company continuously advances its portfolio to
address their needs. A transparent program of customer reviews and datasheets, combined with industry-leading validation initiatives, gives researchers increased confidence in their results.
Founded in 1998 and headquartered in Cambridge, U.K., the Company has served customers in more than 130 countries. Abcams American Depositary Shares
(ADSs) trade on the Nasdaq Global Select Market (Nasdaq: ABCM).
For more information, please visit www.abcam.com or www.abcamplc.com.